Coupa Software acquires LLamasoft for $1.5B - Breaking The News
Download our appPlay StoreApp Store

Coupa Software acquires LLamasoft for $1.5B

United States global technology platform for Business Spend Management, Coupa Software, said on Monday it has acquired another US software development company LLamasoft in a deal worth $1.5 billion.

Coupa CEO and chairman Rob Bernshteyn said: "LLamasoft’s deep supply chain expertise and sophisticated data science and modeling capabilities, combined with the roughly $2 trillion of cumulative transactional spend data we have in Coupa, will empower businesses with the intelligence needed to pivot on a dime."

Donna Wilczek, Coupa’s Senior Vice President of Product Strategy and Innovation stated that the company intends to "turn these decisions into spend transactions, bridging the gap between supply chain and procurement while creating more community intelligence and driving smarter decisions faster."

Related Stocks
Coupa Software
Related News
Musk's xAI acquires social media platform X
Billionaire entrepreneur Elon Musk announced on Friday that X.AI Corp. (doing business as xAI) acquired the social media platform X in an all-stock transaction."xAI and X’s futures are intertwined. Today, we officially take the step to combine the data, models, compute, distribution and talent. This combination will unlock immense potential by blending xAI’s advanced AI capability and expertise with X’s massive reach. The combined company will...
Repsol UK to form new unit with NEO Energy
Spanish petrochemical company Repsol S.A. announced on Thursday that its British business will combine with NEO Energy Group's North Sea arm to form Neo Next Energy. The resulting unit will be managed by a joint team, with NEO owning 55% and Repsol 45%."This combination will create a jointly governed business which will call upon the key strengths of both shareholders," Repsol Exploration and Production Executive Managing Director Francisco Gea said....
Merck to buy Hengrui Pharma's drug for up to $1.8B
Merck & Co. Inc. said on Tuesday that it entered into an exclusive license agreement with Jiangsu Hengrui Pharmaceuticals Co. Ltd. for a cardiovascular disease drug HRS-5346, currently in a phase 2 trial in China. Merck will pay $200 million upfront and commit to milestone payments of up to $1.8 billion, as well as royalties on net sales.The drug is an investigational oral small molecule inhibitor of lipoprotein(a) formation (lp(a)). "Elevated blood concentrations of...
Apollo takes 25% stake in BP Pipelines for $1B
BP plc announced on Friday that Apollo Funds will buy a non-controlling 25% stake in its pipelines business for around $1 billion. The transaction is expected to close in the second quarter of 2025. BP Pipelines owns a 12% interest in the Trans-Anatolian gas pipeline (TANAP), which carries natural gas from Azerbaijan across Turkey.BP said the funds will go toward its plan for $20 billion in divestment and other proceeds. "This [deal] unlocks capital from our...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.